Journal of Colon And Rectal Cancer

Aims and Scope

Journal of Colon and Rectal Cancer (JCRC) is an international, open access peer-reviewed journal dedicated to the dissemination of scientific knowledge and practical guidance for the understanding, and diagnosis of colon and rectal cancer. It is the premier resource for researchers, clinicians, and students seeking to understand the full range of issues related to this particular type of cancer.

Scope and Focus of JCRC:

• Advances in screening, imaging, and diagnostic techniques for early detection of colon and rectal cancer.
• Research on genetics, risk factors, and epidemiological studies to understand disease patterns and prevention strategies.
• Innovations in surgical procedures, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy for treatment.
• Studies on biomedical engineering, nuclear medicine, and radiology in cancer diagnosis and management.
• Exploration of clinical decision-making processes and treatment planning to improve patient care.
• Insights into patient survivorship, post-treatment rehabilitation, and quality of life.
• Public health approaches, including awareness programs, preventive strategies, and healthcare policies.

Additionally, we encourage submissions that discuss the integration of artificial intelligence (AI) technologies with traditional clinical practices, as well as the ethical and regulatory considerations associated with AI implementation in this specific area of oncology. Contributions from the following research areas are invited but not limited to the following branches 

• Diverticulitis
• Crohn’s disease
• Ulcerative Colitis
• Colonoscopy
• Appendectomy
• Prolapse
• Colorectal Cancer
• Inflammatory Bowel Disease
• Obesity
• Anal fistula
• Rectal cancer
• Anal Cancer
• Anastomosis
• Colectomy
• Fecal Incontinence
• Rectovaginal fistula
• Perianal fistula
• Radiotherapy
• Lymphadenectomy
• Nomogram
• Negative Pressure Wound Therapy
• Immunotherapies
• Anastomotic leak
• Pouchitis
• Right hemicolectomy
• Loop ileostomy
• Rectopexy
• Anal dysplasia
• Diverting loop ileostomy
• Chemoradiation
• Mesenchymal stem cell
• Refractory fistula
• Physician perspectives
• Left-sided colon cancer
• Risk factors for colorectal cancer
• Colorectal cancer screening
• Flexible sigmoidoscopy
• Fecal occult blood test
• Stool DNA test
• Virtual colonoscopy
• Biopsy
• Pathology of colorectal cancer
• Staging of colorectal cancer
• Tumor markers for colorectal cancer
• Surgical treatment of colorectal cancer
• Laparoscopic surgery for colorectal cancer
• Robotic surgery for colorectal cancer
• Chemotherapy for colorectal cancer
• Radiation therapy for colorectal cancer
• Targeted therapy for colorectal cancer
• Immunotherapy for colorectal cancer
• Palliative care for colorectal cancer
• Quality of life in colorectal cancer patients
• Colorectal cancer survivorship
• Familial adenomatous polyposis (FAP)
• Lynch syndrome
• Inflammatory bowel disease (IBD) and colorectal cancer
• Colorectal cancer in young adults
• Colorectal cancer in elderly patients
• Colorectal cancer in women
• Colorectal cancer in men
• Metastatic colorectal cancer
• Resectable colorectal liver metastases
• Unresectable colorectal liver metastases
• Colorectal lung metastases
• Colorectal bone metastases
• Colorectal brain metastases
• Colorectal cancer clinical trials
• Colorectal cancer drug development
• Colorectal cancer patient advocacy
• Colorectal cancer research funding
• Colorectal cancer genetics
• Colorectal cancer epigenetics
• Colorectal cancer biomarkers
• Colorectal cancer imaging
• Colorectal cancer diagnosis
• Colorectal cancer prognosis
• Colorectal cancer recurrence
• Colorectal cancer prevention
• Colorectal cancer public health policy
• Colorectal cancer education and awareness
• Colorectal cancer treatment guidelines